Idiopathic Pulmonary Fibrosis clinical trials at UCSD
2 in progress, 0 open to eligible people
Showing trials for
Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Sorry, not currently recruiting here
Study RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.
La Jolla, California and other locations
TTI-101 in Participants With Idiopathic Pulmonary Fibrosis
Sorry, not currently recruiting here
The primary objective of this study is to evaluate the safety and tolerability of oral daily administration of TTI-101 over a 12-week treatment duration in participants with idiopathic pulmonary fibrosis (IPF).
San Diego, California and other locations
Our lead scientists for Idiopathic Pulmonary Fibrosis research studies include Gordon Yung, MD.
Last updated: